Abstract
INSIGHTS INTO PHYTO PHARMACEUTICAL STUDIES OF BLIND-YOUR-EYEMANGROVE EXCOECARIA AGALLOCHA: A REVIEW

Sravani Mekala*, A. Srivani

ABSTRACT

A large variety of plants with varied medicinal and pharmacological implications are used in the traditional system
of medicine. Excoecaria agallocha L. (Euphorbiaceae), a significant mangrove plant, is reviewed in detail in this
article, along with its ethnobotany, Phytochemistry, and pharmacological effects. It has historically been used to
cure a number of illnesses, including epilepsy, ulcers, leprosy, rheumatism, and paralysis. It is also known as the
blind-your-eye mangrove plant because the latex extracted from the bark has a poisonous nature and has the
potential to temporarily blind people. Many phytoconstituents, primarily diterpenoids, triterpenoids, flavonoids,
sterols, and a few other compounds, have been isolated from the plant. The leaves, stem, latex, and root extracts
incorporated 20 distinct polyphenols, 15 terpenoids, and more than 50 volatile components. The plant also shows a
wide range of pharmacological properties, including antioxidant, antibacterial, anti-inflammatory, analgesic,
antiulcer, anticancer, antireverse transcriptase, antihistamine-release, antifilarial, DNA damage protective,
antidiabetic, and antitumor protecting properties. Therefore, this study might assist researchers who seek to
conduct additional research in these domains.

Keywords: Mangroves; Thillai; Terpenoids; Rutin; Antidiabetic; Diterpenoids; Euphorbiaceae; Excoecaria agallocha; Mangrove; Pharmacology; Phytoconstituents.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: APRIL ISSUE PUBLISHED

    APRIL 2026 Issue has been successfully launched on 1 APRIL 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT